Vaxfab Enterprises Ltd
- Market Cap ₹ 171 Cr.
- Current Price ₹ 66.3
- High / Low ₹ 72.0 / 32.5
- Stock P/E
- Book Value ₹ 24.4
- Dividend Yield 0.00 %
- ROCE 19.5 %
- ROE 17.5 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 2.72 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.39% over last 3 years.
- Earnings include an other income of Rs.6.11 Cr.
- Company has high debtors of 414 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2005 | Mar 2006 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.05 | 0.72 | 2.02 | 1.22 | 0.34 | 0.10 | 1.14 | 0.27 | 16.75 | 9.14 | 58.67 | 94.11 | 79.93 | |
| 1.10 | 1.34 | 2.03 | 1.18 | 0.33 | 0.16 | 1.21 | 0.36 | 16.29 | 9.11 | 58.88 | 94.38 | 83.30 | |
| Operating Profit | -0.05 | -0.62 | -0.01 | 0.04 | 0.01 | -0.06 | -0.07 | -0.09 | 0.46 | 0.03 | -0.21 | -0.27 | -3.37 |
| OPM % | -4.76% | -86.11% | -0.50% | 3.28% | 2.94% | -60.00% | -6.14% | -33.33% | 2.75% | 0.33% | -0.36% | -0.29% | -4.22% |
| 0.13 | 0.58 | 0.03 | 0.00 | 0.05 | 0.06 | 0.07 | 0.10 | 0.00 | -4.16 | 0.71 | 5.49 | 6.11 | |
| Interest | 0.08 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.03 |
| Depreciation | 0.06 | 0.04 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.05 | 0.03 | 0.03 | 0.98 |
| Profit before tax | -0.06 | -0.17 | 0.02 | 0.03 | 0.05 | -0.01 | -0.01 | 0.00 | 0.45 | -4.18 | 0.46 | 5.18 | 1.73 |
| Tax % | 0.00% | 0.00% | 50.00% | 33.33% | 20.00% | 0.00% | 0.00% | 26.67% | -14.83% | 26.09% | 29.54% | ||
| -0.06 | -0.17 | 0.01 | 0.02 | 0.04 | -0.01 | -0.01 | 0.00 | 0.33 | -3.57 | 0.34 | 3.64 | -2.84 | |
| EPS in Rs | -0.35 | -1.00 | 0.01 | 0.02 | 0.05 | -0.01 | -0.01 | 0.00 | 0.39 | -4.25 | 0.40 | 1.86 | -2.19 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 142% |
| 3 Years: | 78% |
| TTM: | -38% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 251% |
| 3 Years: | 153% |
| TTM: | -306% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 45% |
| 3 Years: | 59% |
| 1 Year: | 100% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 8% |
| 3 Years: | 9% |
| Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2005 | Mar 2006 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.24 | 0.24 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 1.20 | 8.40 | 8.40 | 8.40 | 19.61 |
| Reserves | 0.39 | 0.23 | 1.63 | 1.65 | 1.69 | 1.67 | 1.66 | 1.66 | 7.76 | 4.19 | 4.53 | 28.20 |
| 0.55 | 0.41 | 0.26 | 0.26 | 0.26 | 0.26 | 0.33 | 0.28 | 0.60 | 0.35 | 8.00 | 8.79 | |
| 0.77 | 0.27 | 0.65 | 0.33 | 0.14 | 0.30 | 0.02 | 0.02 | 9.76 | 5.33 | 91.07 | 116.01 | |
| Total Liabilities | 1.95 | 1.15 | 3.74 | 3.44 | 3.29 | 3.43 | 3.21 | 3.16 | 26.52 | 18.27 | 112.00 | 172.61 |
| 0.41 | 0.15 | 0.00 | 0.11 | 0.10 | 0.09 | 0.08 | 0.08 | 0.07 | 0.02 | 0.12 | 0.09 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.07 | 0.09 | 0.00 | 0.15 | 0.12 | 0.89 | 0.12 | 0.12 | 12.11 | 8.40 | 5.94 | 46.59 |
| 1.47 | 0.91 | 3.74 | 3.18 | 3.07 | 2.45 | 3.01 | 2.96 | 14.34 | 9.85 | 105.94 | 125.93 | |
| Total Assets | 1.95 | 1.15 | 3.74 | 3.44 | 3.29 | 3.43 | 3.21 | 3.16 | 26.52 | 18.27 | 112.00 | 172.61 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2005 | Mar 2006 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.50 | 0.12 | 0.99 | 0.38 | -1.21 | -0.16 | 1.80 | -7.30 | -6.09 | 12.68 | |||
| 0.74 | -0.27 | 0.03 | -0.77 | 0.77 | 0.00 | -11.99 | 3.71 | -1.67 | -42.82 | |||
| -0.34 | 0.11 | -1.02 | 0.36 | 0.44 | 0.18 | 14.36 | -0.25 | 7.65 | 32.03 | |||
| Net Cash Flow | -0.10 | -0.04 | 0.00 | -0.03 | 0.00 | 0.02 | 4.17 | -3.84 | -0.11 | 1.89 | ||
| Free Cash Flow | -0.50 | 0.00 | 0.99 | 0.38 | -1.21 | -0.16 | 1.80 | -7.30 | -6.22 | 12.67 | ||
| CFO/OP | 5,000% | 325% | 10,000% | -633% | 1,729% | 178% | 398% | -23,967% | 2,862% | -4,696% |
Ratios
Standalone / View Consolidated
| Mar 2005 | Mar 2006 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 173.81 | 131.81 | 290.92 | 47.87 | 171.76 | 949.00 | 461.05 | 1,095.00 | 87.38 | 156.54 | 130.15 | 414.45 |
| Inventory Days | 89.02 | 17.38 | 158.79 | 162.59 | 608.33 | 1,642.50 | 73.00 | 365.00 | 107.66 | 23.61 | 419.65 | 0.00 |
| Days Payable | 316.04 | 156.43 | 131.98 | 102.86 | 162.22 | 1,022.00 | 0.00 | 0.00 | 221.98 | 123.94 | 555.16 | |
| Cash Conversion Cycle | -53.20 | -7.24 | 317.72 | 107.60 | 617.88 | 1,569.50 | 534.05 | 1,460.00 | -26.94 | 56.21 | -5.37 | 414.45 |
| Working Capital Days | 215.52 | 278.82 | 341.51 | 538.52 | 912.50 | 1,715.50 | 515.48 | 2,460.37 | 1.09 | 137.37 | 39.19 | -0.62 |
| ROCE % | -31.07% | 0.97% | 1.60% | -0.32% | -0.32% | 0.00% | 4.52% | 0.81% | -2.60% | 19.53% |
Insights
In beta| Mar 2025 | |
|---|---|
| Number of business segments count |
|
| Permanent employees on rolls count |
Extracted by Screener AI
Documents
Announcements
- Shareholder Meeting / Postal Ballot-Outcome of AGM
- Closure of Trading Window
-
Board Meeting Intimation for For Considering And Approving Board Meeting To Be Held On Thursday, October 01, 2026
- Board meeting on 1 Oct 2026 to consider fundraising via equity or other securities.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
-
Clarification That Annual General Meeting Will Be Held On September 29 2026
- 43rd AGM on 29 Sep 2026; approve results, MD reappointment, auditor appointment, and raise capital to Rs. 50 crore.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
Business evolution
The company, incorporated in 1983, was formerly Ellora Trading Ltd and was renamed Vaxfab Enterprises Ltd. It transitioned from agricultural product trading to textiles and clothing, now broadly classified as trading of goods.[1] [2]